Core Viewpoint - The company reported a steady performance in its 2025 semi-annual report, with revenue and net profit showing positive year-on-year growth, indicating resilience in its operations despite macroeconomic challenges [1][2]. Financial Performance - For the first half of 2025, the company achieved revenue of 5.006 billion yuan, up 8% year-on-year, and a net profit attributable to shareholders of 581 million yuan, up 10% year-on-year [1]. - In Q2 2025, the company recorded revenue of 2.645 billion yuan, a 5% increase year-on-year, but a net profit of 305 million yuan, which represents a 4% decline year-on-year [1]. - The gross margin for Q2 2025 was 16.5%, unchanged year-on-year, while the expense ratio was 5.1%, an increase of 0.1 percentage points year-on-year [1]. Business Segments Performance - Revenue growth varied across different business segments in H1 2025: - Fatty alcohol (acid) +60% - PVC -14% - Sulfonated pharmaceuticals +38% - Sulfur +58% - Steam -2% - Photovoltaic power -11% - Dock loading and unloading -21% [1]. - Sales volume changes were as follows: - Fatty alcohol -2% - PVC -1% - Sulfonated pharmaceuticals +34% - Sulfur +12% - Steam +10% - Photovoltaic power -4% - Dock loading and unloading -5% [1]. - Price changes year-on-year were: - Fatty alcohol +64% - PVC -13% - Sulfonated pharmaceuticals +3% - Sulfur +41% - Steam -10% - Photovoltaic power -8% - Dock loading and unloading -17% [1]. Strategic Initiatives - The company is focusing on its core industry advantages in cogeneration, ensuring high production capacity of its main facilities, and pursuing key project construction and technological upgrades to enhance future growth potential [1]. - The company's circular economy advantages are becoming more prominent in the context of moderate macroeconomic growth, demonstrating its anti-cyclical capabilities [1]. Shareholder Returns - The company has implemented a proactive and stable dividend policy, proposing a cash dividend of 2 yuan per 10 shares, totaling approximately 265 million yuan, which represents 45.66% of net profit [2]. - As of the end of July, the company had repurchased 21,526,100 shares, accounting for 1.59% of total share capital, with a total expenditure of nearly 186 million yuan [2]. - The company is accelerating the construction of its second-phase projects for fatty alcohol and PVC, with expectations for trial production in the second half of the year, which may enhance future performance [2]. Investment Outlook - The company is projected to achieve net profits attributable to shareholders of 1.26 billion yuan, 1.44 billion yuan, and 1.57 billion yuan for the years 2025 to 2027, maintaining a "strong buy" rating [3].